| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 41.4796 | 11 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.4495 | 34 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.8886 | 13 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.4443 | 24 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.0741 | 13 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.4199 | 34 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.3404 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.7043 | 31 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.076 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.0154 | 45 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.4912 | 34 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.9862 | 27 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 38.4147 | 3 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.0416 | 22 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.5163 | 25 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 57.3031 | 62 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.1017 | 33 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.2371 | 28 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.0041 | 27 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 39.5084 | 5 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.985 | 13 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.1091 | 23 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.7887 | 26 |